Ceftolozane-Tazobactam for Directed Treatment of Pseudomonas Aeruginosa Bacteremia and Pneumonia in Patients With Hematological Malignancies and Hematopoietic Stem Cell Transplantation
PHASE4
The goal of this clinical trial is to learn whether the antibiotic ceftoloz...
The primary purpose of the Research Database is to have a comprehensive sou...
Status
Recruiting
Location
Center for International Blood and Marrow Transplant Research
Start Date
2002-07
Trial ID
NCT01166009
Tissue-resident Immune Cell Subsets in aGVHD
N/A
This is a prospective study investigating the role of tissue-resident immun...
Status
Recruiting
Location
Nanfang Hospital, Southern Medical University
Start Date
2024-11-16
Trial ID
NCT06708507
Safety and Efficacy of Donor T-lymphocytes Depleted ex Vivo of Host Alloreactive T-cells (ATIR) in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor
PHASE2
The purpose of this study is to determine whether ATIR is safe and effectiv...
Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer
NA
This clinical trial studies fludarabine phosphate, low-dose total body irra...
Idarubicin, Cytarabine, and Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome
PHASE2
RATIONALE: Drugs used in chemotherapy, such as idarubicin and cytarabine, w...